Literature DB >> 24686119

The bromodomain: from epigenome reader to druggable target.

Roberto Sanchez1, Jamel Meslamani1, Ming-Ming Zhou1.   

Abstract

Lysine acetylation is a fundamental post-translational modification that plays an important role in the control of gene transcription in chromatin in an ordered fashion. The bromodomain, the conserved structural module present in transcription-associated proteins, functions exclusively to recognize acetyl-lysine on histones and non-histone proteins. The structural analyses of bromodomains' recognition of lysine-acetylated peptides derived from histones and cellular proteins provide detailed insights into the differences and unifying features of biological ligand binding selectivity by the bromodomains. Newly developed small-molecule inhibitors targeting bromodomain proteins further highlight the functional importance of bromodomain/acetyl-lysine binding as a key mechanism in orchestrating molecular interactions and regulation in chromatin biology and gene transcription. These new studies argue that modulating bromodomain/acetyl-lysine interactions with small-molecule chemicals offer new opportunities to control gene expression in a wide array of human diseases including cancer and inflammation. This article is part of a Special Issue entitled: Molecular mechanisms of histone modification function.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bromodomain; Gene transcription; Small molecule inhibitors

Mesh:

Substances:

Year:  2014        PMID: 24686119      PMCID: PMC4099289          DOI: 10.1016/j.bbagrm.2014.03.011

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  112 in total

Review 1.  The bromodomain interaction module.

Authors:  Panagis Filippakopoulos; Stefan Knapp
Journal:  FEBS Lett       Date:  2012-05-03       Impact factor: 4.124

2.  BET bromodomain inhibition as a novel strategy for reactivation of HIV-1.

Authors:  Camellia Banerjee; Nancie Archin; Daniel Michaels; Anna C Belkina; Gerald V Denis; James Bradner; Paola Sebastiani; David M Margolis; Monty Montano
Journal:  J Leukoc Biol       Date:  2012-07-16       Impact factor: 4.962

3.  Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification.

Authors:  Minjia Tan; Hao Luo; Sangkyu Lee; Fulai Jin; Jeong Soo Yang; Emilie Montellier; Thierry Buchou; Zhongyi Cheng; Sophie Rousseaux; Nisha Rajagopal; Zhike Lu; Zhen Ye; Qin Zhu; Joanna Wysocka; Yang Ye; Saadi Khochbin; Bing Ren; Yingming Zhao
Journal:  Cell       Date:  2011-09-16       Impact factor: 41.582

4.  Cyclin-dependent kinase inhibitor dinaciclib interacts with the acetyl-lysine recognition site of bromodomains.

Authors:  Mathew P Martin; Sanne H Olesen; Gunda I Georg; Ernst Schönbrunn
Journal:  ACS Chem Biol       Date:  2013-09-10       Impact factor: 5.100

5.  The structural basis for the recognition of acetylated histone H4 by the bromodomain of histone acetyltransferase gcn5p.

Authors:  D J Owen; P Ornaghi; J C Yang; N Lowe; P R Evans; P Ballario; D Neuhaus; P Filetici; A A Travers
Journal:  EMBO J       Date:  2000-11-15       Impact factor: 11.598

6.  Inhibition of BET bromodomain targets genetically diverse glioblastoma.

Authors:  Zhixiang Cheng; Yuanying Gong; Yufang Ma; Kaihua Lu; Xiang Lu; Larry A Pierce; Reid C Thompson; Susanne Muller; Stefan Knapp; Jialiang Wang
Journal:  Clin Cancer Res       Date:  2013-02-12       Impact factor: 12.531

7.  Druggability analysis and structural classification of bromodomain acetyl-lysine binding sites.

Authors:  Lewis R Vidler; Nathan Brown; Stefan Knapp; Swen Hoelder
Journal:  J Med Chem       Date:  2012-07-12       Impact factor: 7.446

8.  UniProt Knowledgebase: a hub of integrated protein data.

Authors:  Michele Magrane
Journal:  Database (Oxford)       Date:  2011-03-29       Impact factor: 3.451

9.  Discovery of novel small-molecule inhibitors of BRD4 using structure-based virtual screening.

Authors:  Lewis R Vidler; Panagis Filippakopoulos; Oleg Fedorov; Sarah Picaud; Sarah Martin; Michael Tomsett; Hannah Woodward; Nathan Brown; Stefan Knapp; Swen Hoelder
Journal:  J Med Chem       Date:  2013-10-03       Impact factor: 7.446

10.  Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer.

Authors:  Anastasia Wyce; Yan Degenhardt; Yuchen Bai; BaoChau Le; Susan Korenchuk; Ming-Chih Crouthame; Charles F McHugh; Robert Vessella; Caretha L Creasy; Peter J Tummino; Olena Barbash
Journal:  Oncotarget       Date:  2013-12
View more
  57 in total

1.  Bromodomain and hedgehog pathway targets in small cell lung cancer.

Authors:  Gurmeet Kaur; Russell A Reinhart; Anne Monks; David Evans; Joel Morris; Eric Polley; Beverly A Teicher
Journal:  Cancer Lett       Date:  2015-12-10       Impact factor: 8.679

2.  Distinct Roles for BET Family Members in Estrogen Receptor α Enhancer Function and Gene Regulation in Breast Cancer Cells.

Authors:  Shino Murakami; Rui Li; Anusha Nagari; Minho Chae; Cristel V Camacho; W Lee Kraus
Journal:  Mol Cancer Res       Date:  2019-09-24       Impact factor: 5.852

Review 3.  Quantitative proteomic analysis of histone modifications.

Authors:  He Huang; Shu Lin; Benjamin A Garcia; Yingming Zhao
Journal:  Chem Rev       Date:  2015-02-17       Impact factor: 60.622

4.  Rice Homeodomain Protein WOX11 Recruits a Histone Acetyltransferase Complex to Establish Programs of Cell Proliferation of Crown Root Meristem.

Authors:  Shaoli Zhou; Wei Jiang; Fei Long; Saifeng Cheng; Wenjing Yang; Yu Zhao; Dao-Xiu Zhou
Journal:  Plant Cell       Date:  2017-05-09       Impact factor: 11.277

5.  Identification of small molecule inhibitors targeting the SMARCA2 bromodomain from a high-throughput screening assay.

Authors:  Tian Lu; Jun-Chi Hu; Wen-Chao Lu; Jie Han; Hong Ding; Hao Jiang; Yuan-Yuan Zhang; Li-Yan Yue; Shi-Jie Chen; Hua-Liang Jiang; Kai-Xian Chen; Hui-Fang Chai; Cheng Luo
Journal:  Acta Pharmacol Sin       Date:  2018-05-24       Impact factor: 6.150

6.  Differential Salt Fractionation of Nuclei to Analyze Chromatin-associated Proteins from Cultured Mammalian Cells.

Authors:  Christin Herrmann; Daphne C Avgousti; Matthew D Weitzman
Journal:  Bio Protoc       Date:  2017-03-20

7.  Exploiting a water network to achieve enthalpy-driven, bromodomain-selective BET inhibitors.

Authors:  William R Shadrick; Peter J Slavish; Sergio C Chai; Brett Waddell; Michele Connelly; Jonathan A Low; Cynthia Tallant; Brandon M Young; Nagakumar Bharatham; Stefan Knapp; Vincent A Boyd; Marie Morfouace; Martine F Roussel; Taosheng Chen; Richard E Lee; R Kiplin Guy; Anang A Shelat; Philip M Potter
Journal:  Bioorg Med Chem       Date:  2017-11-04       Impact factor: 3.641

8.  Pharmacokinetics-Driven Optimization of 7-Methylimidazo[1,5-a]pyrazin-8(7H)-one as Novel BRD4 Inhibitors.

Authors:  Yifei Yang; Pan Chen; Leilei Zhao; Fangqing Zhang; Huibin Zhang; Jinpei Zhou
Journal:  ACS Med Chem Lett       Date:  2019-11-26       Impact factor: 4.345

9.  RNAs interact with BRD4 to promote enhanced chromatin engagement and transcription activation.

Authors:  Homa Rahnamoun; Jihoon Lee; Zhengxi Sun; Hanbin Lu; Kristen M Ramsey; Elizabeth A Komives; Shannon M Lauberth
Journal:  Nat Struct Mol Biol       Date:  2018-08-03       Impact factor: 15.369

10.  The Bromodomain: A New Target in Emerging Epigenetic Medicine.

Authors:  Steven G Smith; Ming-Ming Zhou
Journal:  ACS Chem Biol       Date:  2015-12-03       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.